Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses

Clinical trial NCT01914952 · COMPLETED

Trial details

NCT number: NCT01914952
Sponsor: Metabolic Technologies Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Focus of the Study is to Examine Plasma HMB Levels After Oral HMB Supplementation

Start date: 2013-05-01
Primary completion: 2014-05-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.